Thyroid Neoplasms
📧 Sign up to get email alerts when something new happens for Thyroid Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-05EMA Authorised: Caprelsa (vandetanib) — Esteve Pharmaceuticals, S.A.
Caprelsa (vandetanib) has been authorised by the EMA for thyroid neoplasms.
-
EMA approval · 2026-07-22EMA Authorised: Cometriq (cabozantinib) — Ipsen Pharma
Cometriq (cabozantinib) has been authorised in the EU for therapeutic use in thyroid neoplasms by Ipsen Pharma.
-
EMA approval · 2026-07-10EMA Authorised: Cometriq (cabozantinib) — Ipsen Pharma
Cometriq (cabozantinib) has been authorised in the European Union for thyroid neoplasms.
-
EMA approval · 2026-07-03EMA Authorised: Retsevmo (selpercatinib) — Eli Lilly Nederland B.V.
Authorization of Retsevmo (selpercatinib) by EMA for use in non-small cell lung cancer and thyroid neoplasms.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
This clinical trial aims to perform a comprehensive molecular analysis of endocrine neoplasms and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-03-26EMA Authorised: Lenvima (lenvatinib mesilate) — Eisai GmbH
EMA authorised Lenvima (lenvatinib mesilate) by Eisai GmbH for thyroid neoplasms, under accelerated assessment, with a decision dated 26 Mar…
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: TRAIL Study: Feasibility and Pilot [NA]
This entry notes an ongoing feasibility and pilot trial called TRAIL, sponsored by Dartmouth-Hitchcock Medical Center. It is recruiting part…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study [NA]
A pilot clinical trial evaluating EMDR integrative group and individual treatment for cancer patients, including those with thyroid neoplasm…
-
EMA approval · 2026-02-27EMA Authorised: Cometriq (cabozantinib) — Ipsen Pharma
The European Medicines Agency authorised Cometriq (cabozantinib) for thyroid neoplasms, with Ipsen Pharma as the marketing authorisation hol…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors [Phase 2, Phase 3]
Clinical trial update reporting safety and efficacy data for using dexmedetomidine to control hemodynamics during resection of active thyroi…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Clinical trial update indicates the study on neoadjuvant treatment for locally advanced thyroid cancer is currently recruiting at Fujian Med…
-
EMA approval · 2026-02-12EMA Authorised: Retsevmo (selpercatinib) — Eli Lilly Nederland B.V.
The European Medicines Agency authorised Retsevmo (selpercatinib) for RET fusion-positive cancers in the EU, including non-small cell lung c…
-
EMA approval · 2025-12-08EMA Authorised: Caprelsa (vandetanib) — Sanofi B.V.
The European Medicines Agency authorised Caprelsa (vandetanib) for thyroid neoplasms, including medullary thyroid carcinoma, with Sanofi B.V…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment [Phase 1]
Phase 1 trial update on LOXO-260 for RET-altered cancers that progressed after prior treatment, including Non-Small Cell Lung Cancer and Thy…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy [NA]
The trial evaluates near-infrared autofluorescence (NIRAF) for identifying parathyroid glands during total thyroidectomy and reports potenti…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy [NA]
A completed clinical trial evaluating the benefits of near-infrared autofluorescence (NIRAF) detection to identify parathyroid glands during…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Peri-operative BiPAP to Prevent Tracheostomy in High-Risk Bilateral Vocal-Cord Paralysis (BVCP) [NA]
A not-yet-recruiting clinical trial evaluating peri-operative BiPAP to prevent tracheostomy in patients with high-risk bilateral vocal cord …
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer
A clinical trial update for the RET-US study investigating ultrasound-based prediction of RET alterations and lateral-neck metastasis in pap…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)
A clinical trial evaluates dual-channel near-infrared autofluorescence imaging with AI analysis to locate parathyroid glands during surgery.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study [Phase 4]
A Phase 4 real-world cohort study from Fujian Medical University examining genotype-driven neoadjuvant therapy for locally advanced thyroid …
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery [Phase 1, Phase 2]
Bevonescein was studied in a Phase 1/2 trial to highlight nerves during head and neck surgery, including procedures for parotid and thyroid …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Thermal Ablation of Cervical Metastases From Thyroid Carcinoma [NA]
Clinical trial update shows a study of thermal ablation for cervical metastases from thyroid carcinoma is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Role of Frozen Section in Categorization of Thyroid Follicular Neoplasm [NA]
Clinical trial examining the role of frozen section in categorizing thyroid follicular neoplasms; currently not recruiting.
-
EMA approval · 2025-02-19EMA Authorised: Thyrogen (thyrotropin alfa) — Sanofi B.V.
The European Medicines Agency has authorised Thyrogen (thyrotropin alfa) for use in thyroid neoplasms. The marketing authorization holder is…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Dual-port Trans-subclavian Thyroid Endoscopic Surgery [NA]
A clinical trial update indicates a study of dual-port trans-subclavian thyroid endoscopic surgery is underway. The trial is currently recru…